comparemela.com

Latest Breaking News On - Nathalie meetz - Page 3 : comparemela.com

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care

United statesNathalie meetzThomas schineckerSystem softwareEuropean unionRoche groupRoche group media relationsDow jones sustainability indicesChugai pharmaceuticalCancer factsInvestegate announcementsInvestegate company announcementsF hoffmann la roche ltdLobenewswire and globenewswire

F Hoffmann-La Roche Ltd: Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics

The VENTANA DP 600 is Roche's new, high-capacity slide scanner that creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and determine a patient's treatment.Cancer

United statesNathalie meetzBirgit masjostLoren kalmThomas schineckerSabine borngrGerard tobinBruno eschliResearch useRoche groupRoche group media relationsRoche digital pathologyDow jones sustainability indicesChugai pharmaceutical

F Hoffmann-La Roche Ltd: Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of COVID-19.Potential

United statesNathalie meetzBirgit masjostLoren kalmThomas schineckerSabine borngrGerard tobinBruno eschliInternational standardWorld health organizationRoche groupDrug administrationRoche group media relationsEmergency use authorizationDow jones sustainability indicesChugai pharmaceutical

Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of. | June 15, 2022

United statesNathalie meetzThomas schineckerLoren kalmInternational standardWorld health organizationRoche groupDrug administrationRoche group media relationsEmergency use authorizationDow jones sustainability indicesChugai pharmaceuticalRoche holding ag stock exchangePress releaseUspected rho ch0012032113

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

United statesNathalie meetzThomas schineckerLoren kalmInternational standardWorld health organizationRoche groupDrug administrationRoche group media relationsEmergency use authorizationDow jones sustainability indicesChugai pharmaceuticalInvestegate announcementsInvestegate company announcementsF hoffmann la roche ltdLobenewswire and globenewswire

vimarsana © 2020. All Rights Reserved.